ESC 23: New Guidelines For the Management of Acute Coronary Syndromes

Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes.

Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation Myocardial Infarction (STEMI) and Non-ST Elevation Myocardial Infarction (NSTEMI). The new ESC guidelines for ACS cover both NSTEMI and STEMI.

The combined guidelines outlined a common pathway for the treatment of all patients diagnosed with ACS, including early invasive strategies, antithrombotic treatment strategies, revascularization and a focus on secondary prevention. NSTE-ACS early invasive treatment has also been downgraded to a class IIa recommendation from a class I.

Questions:
-What are the unmet needs of ACS patients in 2023?
-What is new in the guidelines?
-Is there any area that needs more attention?
-What are some of the challenges and opportunities with the implementation of these recommendations?

Recorded on-site at ESC Congress 2023, Amsterdam.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.